Cite
HARVARD Citation
Hansen, A. et al. (2018). Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study. Annals of oncology. pp. 1807-1813. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hansen, A. et al. (2018). Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study. Annals of oncology. pp. 1807-1813. [Online].